Clinical Trial: A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985147) titled 'A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)' on May 07.

Brief Summary: This open-label, multicenter, within-participant dose escalation study examining up to 2 dose levels of DISC-3405 will assess the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of DISC-3405 in participants with polycythemia vera (PV).

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Polycythemia Vera (PV)

Intervention: DRUG: DISC-3405

DISC-3405 is administered subcutaneously.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Disc Medicine, Inc

Disclaimer: Curated by HT Syndi...